tirzepatide glen carbon Personalized Treatment Compounded Tirzepatide (GLP-1/GIP) Injections |
Description
Clinical trial data from the SURMOUNT-5 trial shows tirzepatide produced approximately 47 percent more weight loss than a semaglutide comparator over 72 weeks (average of 50 pounds versus 33 pounds)
Tip: Eat 46 small meals rather than 23 large ones
Meanwhile, the average rise after eating is a healthy 16 mg/dL (0.9 mg/dL)
This is why weight loss can vary from person to person, even when using the same medication
